TL;DR
Anthropic paid over $400 million in stock for Coefficient Bio, a stealth biotech startup with fewer than 10 employees -- the highest per-head acquisition in AI history.
MSM Perspective
TechCrunch and The Information broke the deal details; The Next Web emphasized the extraordinary per-employee valuation of over $40 million per person.
X Perspective
Tech investors on X are calling the Coefficient Bio deal proof that AI companies are racing to own biological modeling capabilities before competitors do.
Anthropic has acquired Coefficient Bio, a stealth biotech startup, in an all-stock deal valued at over $400 million, according to The Information and TechCrunch [1]. The acquisition closed in early April 2026 and represents one of the highest per-employee valuations in technology history: Coefficient Bio has fewer than 10 people [2].
Coefficient Bio was founded last fall and backed by Dimension, a venture capital firm [3]. The startup focused on developing AI models for biological research -- protein folding, drug discovery, and computational biology -- areas where Anthropic's Claude models have shown capability but lack domain-specific training data [4].
The deal signals Anthropic's intent to compete directly in the AI-for-biology space, where DeepMind's AlphaFold has dominated for years. By acquiring a team already working on biological AI models, Anthropic gains specialized expertise without building from scratch [5]. The all-stock structure means Coefficient Bio's founders and employees will hold equity in Anthropic rather than receiving cash [6]. Anthropic has not commented on the deal. The startup's website remains dark.
-- DAVID CHEN, Beijing
Sources & X Posts
News Sources
X Posts